多功能蛋白APE1/Ref1在肝衰竭大鼠肝细胞不同部位的表达意义*

doi:10.3969/j.issn.1672-5069.2016.02.007

摘要/Abstract

摘要： 目的研究多功能蛋白酶脱嘌呤/脱嘧啶核酸内切酶 (APE1/Ref1）在慢加急性肝衰竭大鼠肝细胞不同部位的表达意义。方法将30只SD大鼠随机分为对照组（n=15）和模型组（n=15）。采用四氯化碳（CCL₄）联合D-氨基半乳糖（D-GalN）和内毒素（LPS）注射法制备肝衰竭模型,使用B超监测筛选成功模型。检测血清ALT、AST、总胆红素(TBIL）,采用HE染色观察肝组织病理学变化,采用免疫组化和免疫印迹法检测肝组织胞浆蛋白、胞核蛋白、总蛋白APE1/Ref1的表达。结果本组实验,经B超筛选模型成功率达80%;正常对照组血清ALT、AST和TBIL水平分别为（56.5±16.0） U/L、(178.7±36.5） U/L和（3.2±0.6） μmol/L,均显著低于模型组【（620.4±347.5）U/L、（1077.7±666.1）U/L和（21.2±16.9）μmol /L,均P<0.05】;免疫组化法检测模型组肝组织APE1/Ref1表达水平为（6.8±1.3）IOD,显著低于正常对照组的【（8.1±1.2）IOD,P<0.05】,模型组胞浆蛋白水平为（0.91±0.08）IOD,明显高于正常对照组的【（0.18±0.01）IOD,P<0.01】,而核蛋白和总蛋白水平分别为（0.71±0.01）IOD和（0.92±0.03）IOD,均明显低于正常对照组【（1.41±0.04）IOD和（1.15±0.01）IOD,P<0.05】。结论慢加急性肝衰竭大鼠肝内APE1/Ref1表达呈现由细胞核内转向胞浆内表达的特征,总体表达呈下降水平。

关键词: 肝衰竭, 脱嘌呤/脱嘧啶核酸内切酶, DNA损伤, 氧化应激, 大鼠

Abstract: Objective To investigate the expression of multifunctional protein apurinic/ apyrimidinic endonuclease 1（APE1/Ref1） in different parts of liver cells in rats with acute-on-chronic liver failure （ACLF）. Methods 30 SD rats were random1y divided into normal control （n=15）,and ACLF model group （n=15）. ACLF models were established by intraperitoneal injections of CCL₄ combined with D-GalN and LPS and the establishment of liver failure model was confirmed by ultrasonography. Serum ALT,AST,and TBIL were detected by automatic biochemistry analyzer,pathologic changes in liver were revealed by HE staining,and APE1/Ref1 expression in cytoplasmprotein,nucleoprotein and total protein were detected by immunohistochemistry(IHC） and western blot. Results Success rate of model establishment screened by B ultrasound in this series was as high as 80%;serum ALT, AST and TBIL in control group were significantly lower than those in the model group [（56.5±16.0） U/L vs. （620.4±347.5） U/L,（178.7±36.5） vs. （1077.7±666.1） U/L,（3.2±0.6） μmol/L vs. （21.2±16.9） μmol /L,respectively,P<0.05 for all];the expression of APE1/Ref1 in model group was significantly lower than in the control[（6.8±1.3） IOD vs. （8.1±1.2） IOD,P<0.05];APE1/Ref1 in cytoplasmprotein in model group was significantly higher than that in control group[（0.91±0.08） IOD vs.（0.18±0.01） IOD,P<0.01],while APE1/Ref1 in nucleoprotein and total protein in model group were lower than those in control group[（0.71±0.01） IOD vs. （1.41±0.04） IOD,and （0.92±0.03） vs. （1.15±0.01） IOD,respectively,P<0.05 for both]. Conclusion APE1/Ref1 are co-expressed in hepatocellular cytoplasm and nucleus,presenting transferred expression from intranucleus to intracytoplasm with a declined expression manner.

Key words: Liver failure, Apurinic/apyrimidinic endonuclease 1, DNA damage, Oxidative stress, Rats

刁建新, 代欢, 李海叶, 杨运高. 多功能蛋白APE1/Ref1在肝衰竭大鼠肝细胞不同部位的表达意义^*[J]. 实用肝脏病杂志, 2016, 19(2): 151-155.

Diao Jianxin, Dai Huan, Li Haiye. Expression of multifunctional protein APE1/Ref1 in different parts of liver cells in rats with acute-on-chronic liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 151-155.

参考文献

[1] Hutter RV. CANCER launches accelerated publication:a message from the editor-in-chief. Cancer,2000,88（1）:1.
[2] Jung HJ,Kim HL,Seo YR. Enhanced redox factor 1 （REF1）-modulated p53 stabilization and JNK1 dissociation in response to selenomethionine. Anticancer Res,2013,33（9）: 3645-3651.
[3] 王宇明,汤勃. 2012年新版《肝衰竭诊治指南》诊断进展的解读与探讨. 肝脏,2013,15（4）: 241-244.
[4] Mcgill MR,Jaeschke H. Apoptosis or necrosis in acetaminophen-induced acute liver failure New insights from mechanistic biomarkers. Crit Care Med,2013,41（11）: 2653-2654.
[5] Shukla VK,Das PC,Dixit R,et al. Study of AP endonuclease （APEX1/REF1）,a DNA repair enzyme,in gallbladder carcinoma. Anticancer Res,2012,32（4）:1489-1492.
[6] 刁建新,马文校,代欢,等. B超检测对慢加急性肝衰竭大鼠模型诊断的价值. 广东医学,2014,35（22）:3453-3455.
[7] 方芳,张本春,王惠菊. 慢性乙型肝炎肝脏B超形态学与肝纤维化的相关性分析. 山东医药,2009,49（4）:87-88.
[8] 胡永胜,朱宇,徐毅. 实时超声造影在肝脏良恶性病变鉴别诊断中的应用价值分析. 实用肝脏病杂志,2015,18（2）:197-198.
[9] 李兰娟,段钟平. 肝衰竭诊治指南（2012年版）. 中华移植杂志（电子版）,2013,7（1）:48-56.
[10] 桑伟,王玻玮,陈兰,等. 1571例肝活检患者病因与肝组织病理学特点分析. 实用肝脏病杂志,2014,17（6）:595-599.
[11] Kakisaka K,Kataoka K,Kuroda H,et al. Predictive formula for acute liver failure is useful for predicting the prognosis of patients with acute-on-chronic liver failure. Hepatol Res, 2015,8:1386-6346.
[12] Huang Y,Lei Y,Zhang H,et al. Role of interleukin-18 in human natural killer cell is associated with interleukin-2. Mol Immunol,2010,47（16）:2604-2610.
[13] Li S,Zhao Y,He X,et al. Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J Biol Chem,2002,277（30）:26912-26920.
[14] Liang DY,Liu LM,Ye CG,et al. Inhibition of UII/UTR system relieves acute inflammation of liver through preventing activation of NF-kappaB pathway in ALF mice. PLoS One,2014,8（6）: e64895.
[15] 万智,安宁,朱易萍. 丙氨酸转氨酶的研究现状与进展. 华西医学,2010,25（1）:238-240.
[16] Fung H,Demple B. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell, 2005,17（3）:463-470.
[17] Tell G,Damante G,Caldwell D,et al. The intracellular localization of APE1/Ref-1:more than a passive phenomenon Antioxid Redox Signal,2005,7（3-4）:367-384.
[18] Jackson EB,Theriot CA,Chattopadhyay R,et al. Analysis of nuclear transport signals in the human apurinic/apyrimidinic endonuclease（APE1/Ref1）. Nucleic Acids Res,2005,33（10）: 3303-3312.
[19] Li Y,Liu X,Zhou T,et al. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization. Redox Biol,2014,2（2）:485-494.
[20] 李梦侠,王东. APE1/Ref-1基因结构及其表达调控. 医学分子生物学杂志,2006,3（5）:350-353.

多功能蛋白APE1/Ref1在肝衰竭大鼠肝细胞不同部位的表达意义^*

Expression of multifunctional protein APE1/Ref1 in different parts of liver cells in rats with acute-on-chronic liver failure

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	徐飞, 李伟荣. 黄芪甲苷对CCL₄所致肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 808-811.
[2]	高磊, 曹蕾, 王瑞芳, 冯丹丹, 薛娟. 人脐带间充质干细胞移植对酒精性肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 812-815.
[3]	林秋香, 王雪雯, 黄祖雄, 潘晨. 灯盏花素对肝脏缺血再灌注损伤大鼠肝脏和肠黏膜屏障功能的保护作用*[J]. 实用肝脏病杂志, 2019, 22(5): 636-639.
[4]	石小龙, 杜睿, 秦革萍, 薛华燕, 张宏鑫. 七氟醚对脓毒症大鼠肝损伤的保护作用及其作用机制研究*[J]. 实用肝脏病杂志, 2019, 22(5): 640-643.
[5]	张胥磊, 杨庆余, 韩秋玉, 缪鋆鋆, 蔡仁诚, 马亦旻. 自拟中药治疗非酒精性脂肪性肝病患者血清炎症反应指标水平的变化*[J]. 实用肝脏病杂志, 2019, 22(5): 660-663.
[6]	朱玉成, 闫家微, 孙景坤, 张秋月. 慢加急性肝衰竭患者血清二胺氧化酶水平及其临床意义探讨*[J]. 实用肝脏病杂志, 2019, 22(5): 672-675.
[7]	宋海燕, 陈曦, 张骏飞, 方雪晴, 董静, 陈照林, 潘劲劲, 刘波, 陈从新. 伏立康唑治疗肝衰竭并发肺部真菌感染患者疗效初步研究[J]. 实用肝脏病杂志, 2019, 22(5): 676-679.
[8]	王艳, 苏峰, 李园园, 李舒. 蜂毒溶血肽改善非酒精性脂肪肝大鼠肝组织脂肪沉积作用及其机制研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 474-477.
[9]	张璇, 唐小云, 唐春银, 石学魁, 王惠琦, 张晓东, 沈海萍, 杨春辉. 中药方剂赤白汤对D-氨基半乳糖诱导的急性肝衰竭小鼠肠道菌群的影响研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 478-481.
[10]	王媛, 党盼玉, 王伟. 血浆置换联合连续性血浆透析滤过治疗慢加急性肝衰竭患者临床疗效及其对血浆细胞因子水平的影响[J]. 实用肝脏病杂志, 2019, 22(4): 541-544.
[11]	彭思璐, 刘冰, 孙宏, 林剑, 潘志颖, 邓存良. HBV相关慢加急性肝衰竭患者预后及其影响因素分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 545-548.
[12]	周丽云, 李校天, 李丽, 杨俊超. 1,25（OH）₂D₃通过调节miR-146a水平抑制大鼠肝纤维化的体内和体外观察[J]. 实用肝脏病杂志, 2019, 22(3): 333-336.
[13]	钟宋, 刘玉元, 刘树人, 周国柱, 刘崇文, 欧阳石. 慢性乙型肝炎患者肝组织自然杀伤细胞G2D表达水平的变化及其临床意义[J]. 实用肝脏病杂志, 2019, 22(3): 341-344.
[14]	潘劲劲, 董静, 宋海燕, 张俊飞, 陈照林, 刘波. 应用糖皮质激素治疗核苷（酸）类似物撤药性肝炎患者临床疗效评价[J]. 实用肝脏病杂志, 2019, 22(3): 357-360.
[15]	宋芳娇,朱冰,吕飒,田华,王海波,辛绍杰,游绍莉. 314例药物性肝衰竭患者临床特征分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 216-219.